Posaconazole therapy of disseminated phaeohyphomycosis in a murine model. - Wikidata - awgldk - TriplyDB

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

http://www.wikidata.org/entity/Q40882553

about

Melanized fungi in human disease Black yeasts and their filamentous relatives: principles of pathogenesis and host defense Cytolocalization of the class V chitin synthase in the yeast, hyphal and sclerotic morphotypes of Wangiella (Exophiala) dermatitidis Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.Mycetoma medical therapy.Posaconazole: clinical pharmacology and potential for management of fungal infections.Therapy of infections caused by dematiaceous fungi.Molecular and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Characterization of Clinically Significant Melanized Fungi in India.Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.Dematiaceous fungi.CNS pharmacokinetics of antifungal agents.Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?Use of posaconazole in the treatment of invasive fungal infections.Mycoses of implantation in Latin America: an overview of epidemiology, clinical manifestations, diagnosis and treatment.Efficacy of caspofungin and posaconazole in a murine model of disseminated Exophiala infection.Reflections on the approach to treatment of a mycologic disaster.Posaconazole: a next-generation triazole antifungal.Antifungal therapy in an athymic murine model of chromoblastomycosis by Fonsecaea pedrosoi.Fungal meningoencephalitis caused by Alternaria: a clinical case.Murine model of a disseminated infection by the novel fungus Fonsecaea monophora and successful treatment with posaconazole.Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.A rare case of subcutaneous phaeohyphomycosis caused by a Rhytidhysteron species: a clinico-therapeutic experience.

P2860

Q24633163-1D4155AE-D4B0-4828-9411-07AF117DA5FC Q27028032-00064376-6E8A-4BDC-A49B-7C0AE7277C28 Q30373183-598D879B-AC4B-40EF-B1D0-FFB41678A9FF Q35136368-386332A8-9101-4F36-9635-6C6A6F187CB5 Q35351362-57DD9669-1085-46FF-805C-45F7B4FFCD46 Q36233491-B08B3FC6-2C48-4803-BDEE-64C8E5E7DA1A Q36233517-DCAD3FCB-36C1-4BEC-B5A3-19E57C46A579 Q36253313-5A00D2C7-D060-481D-BBDF-F4581B806494 Q36589297-709763BA-1BB1-4F15-8432-484679B86C1E Q36738130-C236948B-2520-47DB-B264-4397417BB42E Q36909333-960E14CE-522D-48C7-AE1E-97CCBA649484 Q37404840-115FC6E3-3A3E-467B-AE01-8FE1E9D3E63D Q37463387-5DAFFB57-4640-489F-B70C-B06718EBC98A Q37810083-F39415FF-0DE4-435B-AD10-F04C5697DEA0 Q37815477-B739EE40-DA6F-4690-801B-36E455778230 Q38504361-289BA10E-64DF-4386-B29D-70022710F149 Q39767419-437C1B62-7F3A-4660-878D-A05D897FF89E Q40188974-E14E3102-9A26-40C6-B66E-3836C36CA586 Q41906983-9A0BBBCA-9FC6-4BBC-9693-CA60A89B5FCB Q42275612-645CD1B3-36B7-4D19-AFB3-9B4E3B4D6F1A Q42929693-761A9232-D775-4C30-93B7-E4A730A7D3DE Q46486677-CA3B215D-4319-4634-B80E-36D63E63D7A6 Q46884185-7E2B0B8E-EC4D-4B32-9C9E-803D8676AF05

P2860

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

http://www.wikidata.org/entity/Q40882553

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

@en

type

label

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

@en

prefLabel

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

@en

P1433

Q40882553-7394AD0D-66A7-4166-9908-2E702C47965C

P1476

Q40882553-308F265B-C50E-47CE-ADD3-E53C4E6EE587

P2093

Q40882553-058863A9-E6B6-4498-9087-8BD4EFCED286

Q40882553-0A95984D-0537-4F64-8E9D-7DF951835CF3

Q40882553-A9B95F0E-4A8D-47C7-8C79-529A6315350C

Q40882553-B9D6DEE2-8888-417C-99E0-7C542D536908

Q40882553-C02BB8F7-FB1A-49CC-B727-BAD9E3FDA354

P2860

Q40882553-02523030-CE5B-48C5-B856-B15A7CC0B317

Q40882553-1A487C58-B0DA-4D6D-BF17-BEC26894D6DB

Q40882553-32FC3AE1-5530-4EAC-9F68-11AAB64FD739

Q40882553-3BF8E041-D36A-48B1-8DBC-DC6F64D19C62

Q40882553-44527C73-9675-4F84-9F54-D3FE7274B85A

Q40882553-4674E60A-F085-428D-9F4C-330B803E107B

Q40882553-50D58A42-F30A-477C-B77D-2C1D72A9A58D

Q40882553-5EA82F17-F05C-49D0-B1D2-2F7CFF618D4F

Q40882553-61419560-A652-43CC-90D6-B466AA58BF07

Q40882553-64782928-F18E-491F-BE8F-F103728B9A9E

P304

Q40882553-19439ED3-4220-4086-8F50-CEF99CF0DBE3

P31

Q40882553-268F2C19-9E16-4453-8868-F7DFD5FED79E

P356

Q40882553-0C1C22D4-EC57-471A-A3B6-2FBC5C15E990

P407

Q40882553-0E00BD20-38DD-4B64-9DA0-F4D913292048

P433

Q40882553-881E2F9B-381B-473E-81A6-A3CA0F4AFEA9

P478

Q40882553-E8F48515-0258-4BA2-8B9B-64DAD253C31D

P577

Q40882553-25504024-FE3B-4D80-9C58-B2D58AEEA12F

P5875

Q40882553-4EF71009-8BFF-43EA-BE13-119783EBC399

P698

Q40882553-484E957D-E37E-45C9-B95D-A0E64E8A63E6

P932

Q40882553-1592EDF0-506D-4078-AA91-A4B8ED44BA78

P356

AAC.48.6.2288-2291.2004

P1433

Antimicrobial Agents and Chemotherapy

P1476

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model.

@en

P2093

David Loebenberg

http://www.w3.org/2001/XMLSchema#string

Elizabeth Johnson

http://www.w3.org/2001/XMLSchema#string

John R Graybill

http://www.w3.org/2001/XMLSchema#string

Laura K Najvar

http://www.w3.org/2001/XMLSchema#string

Rosie Bocanegra

http://www.w3.org/2001/XMLSchema#string

P2860

Alternaria infection in a patient with acquired immunodeficiency syndrome: case report and review of invasive alternaria infections

Molecular cloning and characterization of WdPKS1, a gene involved in dihydroxynaphthalene melanin biosynthesis and virulence in Wangiella (Exophiala) dermatitidis.

Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.

SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei")

Clinical and mycological spectra of Wangiella dermatitidis infections.

Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays.

Cutaneous phaeohyphomycosis caused by Alternaria longipes in an immunosuppressed patient.

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Te

Subcutaneous phaeohyphomycosis of the finger caused by Exophiala spinifera.

P304

2288-2291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.48.6.2288-2291.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8551585

http://www.w3.org/2001/XMLSchema#string

P698

15155236

http://www.w3.org/2001/XMLSchema#string

P932

415573

http://www.w3.org/2001/XMLSchema#string